Mary E. Kelley
Impact in
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
Papers in
-
- Schizophrenia research and treatment 20
- Epidemiology 17
- Substance Abuse Treatment and Outcomes 9
- HIV, Drug Use, Sexual Risk 6
- Co-authors
- Daniël P. van Kammen (23 shared papers)Helen S. Mayberg (18 shared papers)Joseph Conigliaro (14 shared papers)Boadie W. Dunlop (15 shared papers)Kevin L. Kraemer (10 shared papers)W. Edward Craighead (11 shared papers)Paul E. Holtzheimer (12 shared papers)Stephen A. Maisto (8 shared papers)
- Journals
- Schizophrenia Research (14 papers)American Journal of Psychiatry (8 papers)Biological Psychiatry (7 papers)Psychiatry Research (5 papers)Depression and Anxiety (4 papers)
- Partner nations
- United StatesGermanyBrazil
In The Last Decade
Mary E. Kelley
122 papers receiving 5.1k citations
Mary E. Kelley's Hit Papers
Peers
Comparison fields: 5 of 143
- Biological Psychiatry 437
- Behavioral Neuroscience 301
- Psychiatry and Mental health 1.0k
- Neurology 313
- Cognitive Neuroscience 735
Countries citing papers authored by Mary E. Kelley
This map shows the geographic impact of Mary E. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Kelley more than expected).
Fields of papers citing papers by Mary E. Kelley
This network shows the impact of papers produced by Mary E. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Kelley. The network helps show where Mary E. Kelley may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary E. Kelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder Hit paper breakdown → | 2013 | 357 |
| 2 | 2017 | 211 | |
| 3 | Three questions can detect hazardous drinkers. | 2001 | 190 |
| 4 | 1995 | 155 | |
| 5 | 2010 | 148 | |
| 6 | 2009 | 146 | |
| 7 | 2000 | 142 | |
| 8 | 2001 | 137 | |
| 9 | 2000 | 132 | |
| 10 | 2019 | 118 | |
| 11 | 1998 | 115 | |
| 12 | 2007 | 112 | |
| 13 | 2001 | 111 | |
| 14 | 2010 | 100 | |
| 15 | 1999 | 94 | |
| 16 | 2001 | 94 | |
| 17 | 2017 | 94 | |
| 18 | 2013 | 93 | |
| 19 | 2012 | 88 | |
| 20 | 1991 | 79 |
About Mary E. Kelley
Mary E. Kelley is a scholar working on Psychiatry and Mental health, Epidemiology, General Health Professions, Pharmacology and Cognitive Neuroscience, having authored 126 papers that have together received 5.3k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (20 papers), Substance Abuse Treatment and Outcomes (9 papers), Functional Brain Connectivity Studies (8 papers), Treatment of Major Depression (7 papers), Homelessness and Social Issues (7 papers), Mental Health Research Topics (6 papers), HIV, Drug Use, Sexual Risk (6 papers) and Cannabis and Cannabinoid Research (5 papers). The work is most often cited by research in Biological Psychiatry (437 citations), Behavioral Neuroscience (301 citations), Psychiatry and Mental health (1.0k citations), Neurology (313 citations) and Cognitive Neuroscience (735 citations). Mary E. Kelley has collaborated with scholars based in United States, Germany and Brazil. Frequent co-authors include Daniël P. van Kammen, Helen S. Mayberg, Joseph Conigliaro, Boadie W. Dunlop, Kevin L. Kraemer, W. Edward Craighead, Paul E. Holtzheimer, Stephen A. Maisto, Callie L. McGrath and John A. Gurklis. Their work appears in journals such as Schizophrenia Research, American Journal of Psychiatry, Biological Psychiatry, Psychiatry Research and Depression and Anxiety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.